About Bihua Chen
Form D filings for Interius BioTherapeutics in 2024 list Bihua Chen as director.
Bihua Chen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Bihua Chen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bihua Chen works with at each company, as listed on that company's latest Form D.
Interius BioTherapeutics, Inc. · Form D, Jun 3, 2024
LM
Leon Moulder
Director
TK
Tomas Kiselak
Director
LJ
Leon Moulder, Jr.
Director
DM
Dora Mitchell
Executive officer
PD
Philip Johnson, M.D.
President and Chief Executive Officer, director